25 XP   0   0   10

Genprex Inc
Buy, Hold or Sell?

Let's analyse Genprex together

PenkeI guess you are interested in Genprex Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genprex Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genprex Inc

I send you an email if I find something interesting about Genprex Inc.

Quick analysis of Genprex (30 sec.)










What can you expect buying and holding a share of Genprex? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.21
Expected worth in 1 year
$-0.15
How sure are you?
21.9%

+ What do you gain per year?

Total Gains per Share
$-0.36
Return On Investment
-13.3%

For what price can you sell your share?

Current Price per Share
$2.71
Expected price per share
$0 - $5.41
How sure are you?
50%

1. Valuation of Genprex (5 min.)




Live pricePrice per Share (EOD)

$2.71

Intrinsic Value Per Share

$-4.46 - $-5.20

Total Value Per Share

$-4.25 - $-4.99

2. Growth of Genprex (5 min.)




Is Genprex growing?

Current yearPrevious yearGrowGrow %
How rich?$12.3m$34.5m-$18.2m-112.2%

How much money is Genprex making?

Current yearPrevious yearGrowGrow %
Making money-$7.8m-$5.6m-$2.1m-27.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Genprex (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#664 / 1031

Most Revenue
#955 / 1031

Most Profit
#542 / 1031

Most Efficient
#415 / 1031

What can you expect buying and holding a share of Genprex? (5 min.)

Welcome investor! Genprex's management wants to use your money to grow the business. In return you get a share of Genprex.

What can you expect buying and holding a share of Genprex?

First you should know what it really means to hold a share of Genprex. And how you can make/lose money.

Speculation

The Price per Share of Genprex is $2.71. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genprex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genprex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.21. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genprex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-4.9%-0.16-5.9%-0.12-4.4%-0.14-5.1%-0.16-5.7%
Usd Book Value Change Per Share-0.02-0.7%-0.09-3.3%-0.09-3.5%-0.03-0.9%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.7%-0.09-3.3%-0.09-3.5%-0.03-0.9%0.010.2%
Usd Price Per Share0.39-0.93-1.59-1.92-1.66-
Price to Earnings Ratio-0.74--1.43--3.37--4.12--3.45-
Price-to-Total Gains Ratio-20.82--12.80--17.04--12.41--17.84-
Price to Book Ratio1.86-2.86-2.24-3.18-6.36-
Price-to-Total Gains Ratio-20.82--12.80--17.04--12.41--17.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.71
Number of shares369
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.03
Usd Total Gains Per Share-0.09-0.03
Gains per Quarter (369 shares)-33.21-9.25
Gains per Year (369 shares)-132.83-37.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-133-1430-37-47
20-266-2760-74-84
30-399-4090-111-121
40-531-5420-148-158
50-664-6750-185-195
60-797-8080-222-232
70-930-9410-259-269
80-1063-10740-296-306
90-1196-12070-333-343
100-1328-13400-370-380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.031.00.03.1%1.031.00.03.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%3.016.01.015.0%7.021.04.021.9%7.021.04.021.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.032.00.0%0.00.032.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%3.016.01.015.0%7.021.04.021.9%7.021.04.021.9%

Fundamentals of Genprex

About Genprex Inc

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Fundamental data was last updated by Penke on 2024-03-20 19:19:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Genprex Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genprex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genprex Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Genprex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • -46.6% Return on Assets means that Genprex generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genprex Inc:

  • The MRQ is -46.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.6%TTM-40.4%-6.2%
TTM-40.4%YOY-15.7%-24.6%
TTM-40.4%5Y-29.1%-11.3%
5Y-29.1%10Y-64.6%+35.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.6%-12.5%-34.1%
TTM-40.4%-12.2%-28.2%
YOY-15.7%-11.2%-4.5%
5Y-29.1%-13.4%-15.7%
10Y-64.6%-14.7%-49.9%
1.1.3. Return on Equity

Shows how efficient Genprex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • -63.0% Return on Equity means Genprex generated $-0.63 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genprex Inc:

  • The MRQ is -63.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -51.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-63.0%TTM-51.8%-11.1%
TTM-51.8%YOY-16.8%-35.0%
TTM-51.8%5Y-33.4%-18.5%
5Y-33.4%10Y-77.7%+44.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.0%-15.8%-47.2%
TTM-51.8%-15.7%-36.1%
YOY-16.8%-13.9%-2.9%
5Y-33.4%-18.3%-15.1%
10Y-77.7%-19.2%-58.5%

1.2. Operating Efficiency of Genprex Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genprex is operating .

  • Measures how much profit Genprex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genprex Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Genprex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genprex Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y-7.396-7.396

1.3. Liquidity of Genprex Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genprex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.96 means the company has $2.96 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genprex Inc:

  • The MRQ is 2.964. The company is able to pay all its short-term debts. +1
  • The TTM is 4.483. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.964TTM4.483-1.519
TTM4.483YOY16.178-11.695
TTM4.4835Y28.905-24.422
5Y28.90510Y20.948+7.956
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9643.986-1.022
TTM4.4834.440+0.043
YOY16.1785.552+10.626
5Y28.9056.158+22.747
10Y20.9486.492+14.456
1.3.2. Quick Ratio

Measures if Genprex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Quick Ratio of 2.70 means the company can pay off $2.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genprex Inc:

  • The MRQ is 2.700. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.295. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.700TTM4.295-1.596
TTM4.295YOY15.805-11.510
TTM4.2955Y26.772-22.477
5Y26.77210Y19.018+7.755
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7003.638-0.938
TTM4.2954.168+0.127
YOY15.8055.515+10.290
5Y26.7726.012+20.760
10Y19.0186.209+12.809

1.4. Solvency of Genprex Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genprex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genprex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.26 means that Genprex assets are financed with 26.1% credit (debt) and the remaining percentage (100% - 26.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genprex Inc:

  • The MRQ is 0.261. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.206. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.261TTM0.206+0.055
TTM0.206YOY0.060+0.145
TTM0.2065Y0.085+0.121
5Y0.08510Y0.116-0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2610.335-0.074
TTM0.2060.330-0.124
YOY0.0600.267-0.207
5Y0.0850.367-0.282
10Y0.1160.378-0.262
1.4.2. Debt to Equity Ratio

Measures if Genprex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 35.3% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genprex Inc:

  • The MRQ is 0.353. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.265. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.353TTM0.265+0.087
TTM0.265YOY0.065+0.200
TTM0.2655Y0.102+0.163
5Y0.10210Y0.193-0.091
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3530.376-0.023
TTM0.2650.398-0.133
YOY0.0650.334-0.269
5Y0.1020.429-0.327
10Y0.1930.476-0.283

2. Market Valuation of Genprex Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genprex generates.

  • Above 15 is considered overpriced but always compare Genprex to the Biotechnology industry mean.
  • A PE ratio of -0.74 means the investor is paying $-0.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genprex Inc:

  • The EOD is -5.054. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.737. Based on the earnings, the company is expensive. -2
  • The TTM is -1.427. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.054MRQ-0.737-4.318
MRQ-0.737TTM-1.427+0.690
TTM-1.427YOY-3.368+1.941
TTM-1.4275Y-4.124+2.698
5Y-4.12410Y-3.451-0.673
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.054-2.643-2.411
MRQ-0.737-2.418+1.681
TTM-1.427-2.742+1.315
YOY-3.368-4.123+0.755
5Y-4.124-6.257+2.133
10Y-3.451-6.478+3.027
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genprex Inc:

  • The EOD is -8.233. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.200. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.010. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.233MRQ-1.200-7.033
MRQ-1.200TTM-2.010+0.811
TTM-2.010YOY-4.687+2.677
TTM-2.0105Y-5.294+3.284
5Y-5.29410Y-5.770+0.476
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.233-3.244-4.989
MRQ-1.200-2.939+1.739
TTM-2.010-3.478+1.468
YOY-4.687-5.592+0.905
5Y-5.294-8.473+3.179
10Y-5.770-8.881+3.111
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genprex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.86 means the investor is paying $1.86 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genprex Inc:

  • The EOD is 12.730. Based on the equity, the company is expensive. -2
  • The MRQ is 1.855. Based on the equity, the company is underpriced. +1
  • The TTM is 2.862. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.730MRQ1.855+10.875
MRQ1.855TTM2.862-1.007
TTM2.862YOY2.237+0.625
TTM2.8625Y3.176-0.314
5Y3.17610Y6.364-3.188
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.7302.124+10.606
MRQ1.8552.041-0.186
TTM2.8622.118+0.744
YOY2.2372.915-0.678
5Y3.1763.682-0.506
10Y6.3644.114+2.250
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genprex Inc.

3.1. Institutions holding Genprex Inc

Institutions are holding 8.492% of the shares of Genprex Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.07330182660000
2023-12-31CVI Holdings LLC1.04020.294618256-1349794-68.5854
2023-12-31Geode Capital Management, LLC0.8292049284200
2023-12-31BlackRock Inc0.7667045568800
2023-12-31Renaissance Technologies Corp0.60490.00013595003595000
2023-12-31State Street Corporation0.2901017243900
2023-12-31Squarepoint Ops LLC0.19820.00011177861177860
2023-12-31Commonwealth Equity Services Inc0.18050.00011073001073000
2023-12-31IHT Wealth Management, LLC0.14030.00098337210001.214
2023-12-31Northern Trust Corp0.137708186100
2023-12-31Morgan Stanley - Brokerage Accounts0.10594591461832.5996
2023-12-31Silvercrest Asset Management Group LLC0.09420.00015600000
2023-12-31Staley Capital Advisers Inc0.08410.00065000000
2023-12-31UBS Group AG0.072504311623438119.1076
2023-12-31StoneX Group Inc0.05910.0013515000
2023-12-31TCG Advisory Services, LLC0.05640.00053350012503.876
2023-12-31Group One Trading, LP0.055603305229398804.543
2023-12-31VERUS CAPITAL PARTNERS, LLC0.05220.000931000-57500-64.9718
2023-12-31VISIONARY HORIZONS LLC0.05050.005630000300000
2023-12-31Millennium Management LLC0.0475028226282260
Total 7.93320.30394715147-694778-14.7%

3.2. Funds holding Genprex Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Extended Market Index0.48990.000229114500
2023-09-30BlackRock Extended Mkt Composite0.12840.00027633500
2024-01-31Fidelity Total Market Index0.114606808800
2023-12-31BlackRock Extended Equity Market K0.1120.000166596-134-0.2008
2024-01-31EC SICAV EverCapital Invms UCITS I Ins I0.1010.09526000000
2024-01-31Fidelity Series Total Market Index0.091705449700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06780.00024032600
2023-12-31Northern Trust Extended Eq Market Idx0.06140.00013648600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06140.00013648600
2024-01-31Fidelity Nasdaq Composite Index0.05920.00013515600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05450.000232387610.1887
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.054032101-1095593-97.1534
2024-01-31Spartan Total Market Index Pool E0.053303165900
2024-02-29Vanguard Total Stock Mkt Idx Inv1.897402819310.0035
2023-12-31SSgA U.S. Extended Market Index Class I0.02660.00011580000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.00780.00011497510.0067
2024-01-31Spartan Extended Market Index Pool E0.020.00011186700
2023-12-31Extended Equity Market Fund M0.01390.000182343924.9987
2023-12-31NT US Market Cap Idx Fd - L0.00790469000
2023-12-31Northern Trust Wilshire 50000.00790469000
Total 4.43070.0968949711-1095272-115.3%

3.3. Insider Transactions

Insiders are holding 1.094% of the shares of Genprex Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-04-21Catherine M VaczyBUY50042.8
2023-04-21John Rodney VarnerBUY47542

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Genprex Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.090+375%-0.094+395%-0.025+32%0.007-385%
Book Value Per Share--0.2130.323-34%0.722-71%0.600-65%0.451-53%
Current Ratio--2.9644.483-34%16.178-82%28.905-90%20.948-86%
Debt To Asset Ratio--0.2610.206+27%0.060+331%0.085+206%0.116+125%
Debt To Equity Ratio--0.3530.265+33%0.065+445%0.102+247%0.193+83%
Dividend Per Share----0%-0%-0%-0%
Eps---0.134-0.160+19%-0.118-12%-0.139+4%-0.156+16%
Free Cash Flow Per Share---0.082-0.119+45%-0.086+5%-0.108+31%-0.102+25%
Free Cash Flow To Equity Per Share--0.030-0.039+229%-0.086+383%0.008+277%0.030+1%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.201--------
Intrinsic Value_10Y_min---4.464--------
Intrinsic Value_1Y_max---0.423--------
Intrinsic Value_1Y_min---0.415--------
Intrinsic Value_3Y_max---1.346--------
Intrinsic Value_3Y_min---1.283--------
Intrinsic Value_5Y_max---2.359--------
Intrinsic Value_5Y_min---2.183--------
Market Cap4026707.700-467%22827446.84146359991.725-51%76202612.628-70%76326330.204-70%53703674.232-57%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio12.730+85%1.8552.862-35%2.237-17%3.176-42%6.364-71%
Pe Ratio-5.054-586%-0.737-1.427+94%-3.368+357%-4.124+460%-3.451+369%
Price Per Share2.710+85%0.3950.926-57%1.593-75%1.925-79%1.660-76%
Price To Free Cash Flow Ratio-8.233-586%-1.200-2.010+68%-4.687+291%-5.294+341%-5.770+381%
Price To Total Gains Ratio-142.900-586%-20.823-12.797-39%-17.036-18%-12.408-40%-17.840-14%
Quick Ratio--2.7004.295-37%15.805-83%26.772-90%19.018-86%
Return On Assets---0.466-0.404-13%-0.157-66%-0.291-38%-0.646+39%
Return On Equity---0.630-0.518-18%-0.168-73%-0.334-47%-0.777+23%
Total Gains Per Share---0.019-0.090+375%-0.094+395%-0.025+32%0.007-385%
Usd Book Value--12305492.00016278991.500-24%34550351.250-64%23928834.900-49%15904017.875-23%
Usd Book Value Change Per Share---0.019-0.090+375%-0.094+395%-0.025+32%0.007-385%
Usd Book Value Per Share--0.2130.323-34%0.722-71%0.600-65%0.451-53%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.134-0.160+19%-0.118-12%-0.139+4%-0.156+16%
Usd Free Cash Flow---4756952.000-6110613.500+28%-4122004.345-13%-3941099.019-17%-2761036.606-42%
Usd Free Cash Flow Per Share---0.082-0.119+45%-0.086+5%-0.108+31%-0.102+25%
Usd Free Cash Flow To Equity Per Share--0.030-0.039+229%-0.086+383%0.008+277%0.030+1%
Usd Market Cap4026707.700-467%22827446.84146359991.725-51%76202612.628-70%76326330.204-70%53703674.232-57%
Usd Price Per Share2.710+85%0.3950.926-57%1.593-75%1.925-79%1.660-76%
Usd Profit---7748243.000-7817120.000+1%-5655503.750-27%-5055248.300-35%-3705731.281-52%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.019-0.090+375%-0.094+395%-0.025+32%0.007-385%
 EOD+3 -5MRQTTM+14 -15YOY+10 -195Y+12 -1710Y+10 -19

4.2. Fundamental Score

Let's check the fundamental score of Genprex Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.054
Price to Book Ratio (EOD)Between0-112.730
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.700
Current Ratio (MRQ)Greater than12.964
Debt to Asset Ratio (MRQ)Less than10.261
Debt to Equity Ratio (MRQ)Less than10.353
Return on Equity (MRQ)Greater than0.15-0.630
Return on Assets (MRQ)Greater than0.05-0.466
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Genprex Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.944
Ma 20Greater thanMa 503.814
Ma 50Greater thanMa 1005.397
Ma 100Greater thanMa 2007.448
OpenGreater thanClose2.850
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Total Other Income Expense Net 2828561368-1356-69-13



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets16,644
Total Liabilities4,338
Total Stockholder Equity12,305
 As reported
Total Liabilities 4,338
Total Stockholder Equity+ 12,305
Total Assets = 16,644

Assets

Total Assets16,644
Total Current Assets12,857
Long-term Assets3,787
Total Current Assets
Cash And Cash Equivalents 11,711
Other Current Assets 1,146
Total Current Assets  (as reported)12,857
Total Current Assets  (calculated)12,857
+/-0
Long-term Assets
Property Plant Equipment 11
Intangible Assets 763
Other Assets 3,012
Long-term Assets  (as reported)3,787
Long-term Assets  (calculated)3,787
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,338
Long-term Liabilities0
Total Stockholder Equity12,305
Total Current Liabilities
Accounts payable 1,179
Other Current Liabilities 3,159
Total Current Liabilities  (as reported)4,338
Total Current Liabilities  (calculated)4,338
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock59
Retained Earnings -127,759
Other Stockholders Equity 140,005
Total Stockholder Equity (as reported)12,305
Total Stockholder Equity (calculated)12,305
+/-0
Other
Capital Stock59
Cash and Short Term Investments 11,711
Common Stock Shares Outstanding 57,806
Liabilities and Stockholders Equity 16,644
Net Debt -11,711
Net Invested Capital 12,305
Net Tangible Assets 11,542
Net Working Capital 8,519



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
> Total Assets 
410
0
0
0
1,911
1,277
1,008
1,267
1,267
1,260
12,891
11,049
9,269
9,269
6,264
4,068
3,534
24,640
24,749
23,352
31,367
51,036
48,731
46,327
42,862
39,409
34,565
29,946
25,085
23,320
15,911
16,644
16,64415,91123,32025,08529,94634,56539,40942,86246,32748,73151,03631,36723,35224,74924,6403,5344,0686,2649,2699,26911,04912,8911,2601,2671,2671,0081,2771,911000410
   > Total Current Assets 
250
0
0
0
1,639
954
496
401
401
194
12,540
10,689
8,847
8,847
5,802
3,609
2,977
24,032
24,158
22,711
30,715
50,378
48,062
45,645
39,140
35,703
30,901
26,308
21,473
19,942
12,366
12,857
12,85712,36619,94221,47326,30830,90135,70339,14045,64548,06250,37830,71522,71124,15824,0322,9773,6095,8028,8478,84710,68912,5401944014014969541,639000250
       Cash And Cash Equivalents 
234
0
0
0
1,602
930
468
374
374
161
12,002
10,310
8,601
8,601
4,497
2,548
2,002
23,080
22,127
21,058
27,320
47,069
44,243
42,021
38,629
34,555
30,053
25,516
20,954
18,083
9,956
11,711
11,7119,95618,08320,95425,51630,05334,55538,62942,02144,24347,06927,32021,05822,12723,0802,0022,5484,4978,6018,60110,31012,0021613743744689301,602000234
       Net Receivables 
0
0
0
0
8
0
0
0
9
9
0
9
9
9
11
0
1
1
0
0
0
0
0
0
0
32
0
35
35
3,359
0
0
003,359353503200000001101199909900080000
       Other Current Assets 
16
0
0
0
37
24
28
27
23
23
539
370
237
237
849
259
172
70
1,136
966
385
201
756
749
511
1,116
848
757
484
1,859
2,410
1,146
1,1462,4101,8594847578481,1165117497562013859661,1367017225984923723737053923232728243700016
   > Long-term Assets 
0
0
0
0
272
322
512
866
866
1,066
351
360
422
422
462
459
558
608
592
641
652
659
670
682
3,722
3,706
3,664
3,638
3,612
3,378
3,545
3,787
3,7873,5453,3783,6123,6383,6643,7063,7226826706596526415926085584594624224223603511,0668668665123222720000
       Property Plant Equipment 
1
0
0
0
5
7
10
9
8
8
14
16
24
24
24
24
45
51
46
42
39
37
39
44
49
42
35
29
23
19
15
11
1115192329354249443937394246514524242424161488910750001
       Goodwill 
0
0
0
0
0
0
0
560
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000005600000000
       Intangible Assets 
156
0
0
0
241
261
277
297
297
299
323
326
379
379
421
424
491
536
535
588
602
611
620
627
642
644
666
682
702
722
742
763
763742722702682666644642627620611602588535536491424421379379326323299297297277261241000156
       Long-term Assets Other 
0
0
0
0
26
54
225
560
1,058
760
13
18
398
18
16
12
22
22
11
11
11
11
11
11
3,031
3,020
2,963
2,926
2,887
2,637
2,788
3,012
3,0122,7882,6372,8872,9262,9633,0203,031111111111111222212161839818137601,05856022554260000
> Total Liabilities 
16
0
0
0
286
170
210
395
395
831
301
565
388
388
939
537
511
697
240
376
451
614
1,047
1,162
1,585
2,385
2,154
2,457
2,810
4,835
3,860
4,338
4,3383,8604,8352,8102,4572,1542,3851,5851,1621,04761445137624069751153793938838856530183139539521017028600016
   > Total Current Liabilities 
16
0
0
0
286
170
210
395
395
831
301
565
388
388
939
537
511
697
240
376
451
614
1,047
1,162
1,585
2,385
2,154
2,457
2,810
4,835
3,860
4,338
4,3383,8604,8352,8102,4572,1542,3851,5851,1621,04761445137624069751153793938838856530183139539521017028600016
       Short-term Debt 
0
0
0
0
0
0
0
0
0
279
0
0
0
25
61
62
74
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000074626125000279000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
279
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000279000000000
       Accounts payable 
16
0
0
0
286
139
168
363
629
1,149
301
565
295
206
877
475
436
638
182
321
193
339
370
592
973
1,253
683
684
443
2,212
1,498
1,179
1,1791,4982,2124436846831,2539735923703391933211826384364758772062955653011,14962936316813928600016
       Other Current Liabilities 
0
0
0
0
286
170
210
395
202
831
301
565
93
388
939
537
511
697
240
54
258
614
677
570
612
1,132
1,471
1,773
2,367
2,623
2,362
3,159
3,1592,3622,6232,3671,7731,4711,13261257067761425854240697511537939388935653018312023952101702860000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
973
1,253
683
684
443
2,212
0
0
002,2124436846831,253973000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
26
0
225
560
760
1,012
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001,0127605602250260000
> Total Stockholder Equity
394
0
0
0
1,625
1,107
798
872
429
429
12,590
10,484
8,881
8,881
5,325
3,531
3,024
23,943
24,510
22,976
30,916
50,423
47,684
45,165
41,277
37,025
32,411
27,489
22,275
18,485
12,051
12,305
12,30512,05118,48522,27527,48932,41137,02541,27745,16547,68450,42330,91622,97624,51023,9433,0243,5315,3258,8818,88110,48412,5904294298727981,1071,625000394
   Common Stock
0
0
0
0
0
0
0
0
12
12
14
15
15
15
16
16
19
33
39
39
43
47
48
48
48
48
48
48
48
52
52
59
59525248484848484848474339393319161615151514121200000000
   Retained Earnings Total Equity0-120,011-112,0310-94,992-88,910000-68,898-64,912-58,422-53,194-50,419-46,046-40,479-38,054-35,679-31,984-29,825-26,394-24,208-18,146-17,452-16,7860000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
17,656
17,869
18,093
36,784
36,863
38,691
39,213
40,988
41,570
43,484
69,956
74,890
76,130
89,296
115,287
116,535
0
0
0
121,273
122,433
0
130,463
132,010
0
0132,010130,4630122,433121,273000116,535115,28789,29676,13074,89069,95643,48441,57040,98839,21338,69136,86336,78418,09317,86917,6560000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
15,761
15,995
16,867
17,656
0
17,869
36,784
36,863
0
38,691
40,988
41,570
43,484
69,956
74,890
76,130
89,296
115,287
116,535
117,453
119,247
120,717
121,273
122,433
125,054
130,463
132,010
140,005
140,005132,010130,463125,054122,433121,273120,717119,247117,453116,535115,28789,29676,13074,89069,95643,48441,57040,98838,691036,86336,78417,869017,65616,86715,99515,7610000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-31,668
Operating Income-31,668-31,668
 
Operating Expense (+$)
Research Development17,289
Selling General Administrative14,362
Selling And Marketing Expenses-
Operating Expense31,66831,650
 
Net Interest Income (+$)
Interest Income231
Interest Expense--
Other Finance Cost-0
Net Interest Income231
 
Pretax Income (+$)
Operating Income-31,668
Net Interest Income231
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-31,455-31,668
EBIT - interestExpense = 0
-31,455
-31,455
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--31,455
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-31,455
Tax Provision--
Net Income From Continuing Ops-31,455-31,455
Net Income-31,455
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--231
 

Technical Analysis of Genprex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genprex. The general trend of Genprex is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genprex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genprex Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.8797 < 4.01 < 5.41.

The bearish price targets are: .

Tweet this
Genprex Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genprex Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genprex Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genprex Inc. The current macd is -0.68003356.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genprex price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genprex. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genprex price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genprex Inc Daily Moving Average Convergence/Divergence (MACD) ChartGenprex Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genprex Inc. The current adx is 11.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Genprex shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Genprex Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genprex Inc. The current sar is 4.58465408.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Genprex Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genprex Inc. The current rsi is 25.94. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Genprex Inc Daily Relative Strength Index (RSI) ChartGenprex Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genprex Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genprex price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Genprex Inc Daily Stochastic Oscillator ChartGenprex Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genprex Inc. The current cci is -133.03016587.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Genprex Inc Daily Commodity Channel Index (CCI) ChartGenprex Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genprex Inc. The current cmo is -59.69812404.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genprex Inc Daily Chande Momentum Oscillator (CMO) ChartGenprex Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genprex Inc. The current willr is -91.75824176.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Genprex Inc Daily Williams %R ChartGenprex Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genprex Inc.

Genprex Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genprex Inc. The current atr is 0.49392654.

Genprex Inc Daily Average True Range (ATR) ChartGenprex Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genprex Inc. The current obv is 1,150,077.

Genprex Inc Daily On-Balance Volume (OBV) ChartGenprex Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genprex Inc. The current mfi is 43.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Genprex Inc Daily Money Flow Index (MFI) ChartGenprex Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genprex Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Genprex Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genprex Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.944
Ma 20Greater thanMa 503.814
Ma 50Greater thanMa 1005.397
Ma 100Greater thanMa 2007.448
OpenGreater thanClose2.850
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genprex with someone you think should read this too:
  • Are you bullish or bearish on Genprex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genprex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genprex Inc

I send you an email if I find something interesting about Genprex Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Genprex Inc.

Receive notifications about Genprex Inc in your mailbox!